Anti-atherogenic properties associated with the antioxidant activity from the hydrophilic extracts of Halimeda incrassata (Chlorophyta, Bryopsidales) by Vidal-Novoa, Alexis et al.
  
Vol. 12(4), pp. 208-220, 26 January, 2017 
DOI: 10.5897/AJAR2014.9328 
Article  Number: 68168BC62506 
ISSN 1991-637X 
Copyright ©2017 
Author(s) retain the copyright of this article 
http://www.academicjournals.org/AJAR 
African Journal of Agricultural  
Research 
 
 
 
 
 
 
Full Length Research Paper 
 
Anti-atherogenic properties associated with the 
antioxidant activity from the hydrophilic extracts of 
Halimeda incrassata (Chlorophyta, Bryopsidales) 
 
Alexis Vidal-Novoa1, Ariadna Costa-Mugica1, Yenisleidy Zulueta-Díaz1, Daylín Diaz-Gutierrez1, 
Ana Mara de Oliveira e Silva2*, Ana María Vazquez3, Claudina Zaldívar-Muñoz1, Dalva 
Assunçao Portari de Mancini4 and Jorge Mancini-Filho2 
 
1
Department of Biochemistry, Faculty of Biology, University of Havana, Cuba.  
2
Department of Food and Experimental Nutrition, Faculty of Pharmaceutical Sciences, University of Sao Paulo, Brazil.  
3
Faculty of Pharmacy, Université de Montréal, Canada.
 
3
Center for Molecular Inmunology, La Habana, Cuba.
 
4
Institute Butantan, Sao Paulo, Brazil. 
 
Received 12 November, 2014; Accepted 29 October, 2015 
 
Seaweeds are a source of natural antioxidants having potential application in oxidative stress and 
associated diseases. In this work, anti-atherogenic properties associated with the antioxidant activity 
from the hydrophilic extracts of Halimeda incrassata were studied. The phenolic content assessed in 
the aqueous extract and fraction phenolic acids (FPA) was 0.13 ± 0.05 and 0.47 ± 0.09 mg of gallic acid 
equivalents (GAE)/g dry seaweed, respectively. In DPPH
•
, radical scavenging assay fractions exhibited a 
dependent concentration. The seaweeds extract inhibited the desoxirribose oxidation in the presence 
or absence of EDTA (IC50 = 1.91± 0.09 mg/mL) (IC50 = 2.95 ± 0.01 mg/mL). In vivo antioxidant properties 
of FPA-H.incrassata were investigated in rats with a CCl4-induced liver injury. Pre-treatment with H. 
incrassata led to approximately 50% reductions in liver TBARS levels.  The treatment with H. incrassata 
FPA also increased the activity of the CAT enzyme, which in turn resulted in an enhanced antioxidant 
defense. The expression of Catalase by PCR-RT technique demonstrated a higher gene expression 
when compared with that which was observed in the CCl4-treated group. Antiatherogenic properties 
were studied in the inhibition of lipoprotein oxidation mediated by Cu
2+
 or HRP/H2O2, free radical 
scavenging, and metal ion chelation, and it was dose dependent with a higher concentration needed for 
the aqueous extract than for the FPA fraction. Antioxidant activity was also improved in macrophages 
as evaluated in the cell supernatant (by TBARS formation); and by luminol enhanced 
chemiluminescence after cell activation with zymosan; and a degree of cell lipoperoxidation was 
decreased by the Halimeda incrassata extract. The results of this work add to the antioxidant potential 
of the seaweed for its application in oxidative stress associated conditions.  
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INTRODUCTION 
 
Oxidative stress is involved in a variety of pathologies 
and indeed it is presently considered a common factor in 
chronic non transmissible diseases as like 
atherosclerosis (Sanchez-Recalde and Kaski, 2001). 
Hence, among the most interesting alternatives for the 
modulation of oxidative stress as a target to halt the 
development of atherosclerosis, antioxidant effects have 
been sought at different stages of the disease: LDL 
oxidation, macrophage activation, foam cell formation, 
smooth muscle cell migration and advanced plaque 
remodeling (Kaliora et al., 2006); and then multiple 
mechanisms have been proposed for targeting an 
atherogenesis associated oxidative stress (Stocker and 
Keaney, 2004). 
Seaweeds have combinations of highly developed 
antioxidant defense systems, allowing them to preserve 
structural integrity before different kinds of environmental 
stresses. However, they possess a wide diversity of 
bioactive compounds from amino acids, such as 
micosporines, polysaccharides, carotenoids, terpenoids, 
and an especially high phenolic content (Dutra-Rocha et 
al., 2007). Their unique composition makes them 
attractive candidates for their application in the 
antioxidant field. A correlation has also been found 
between the consumption of phenolic compounds in 
general, and seaweeds in particular, and the incidence of 
cardiovascular diseases (Bocanegra et al., 2009).  
In the quest for more potent antioxidants from natural 
sources, our group has been especially interested in 
studying the beneficial properties of seaweed from the 
Halimeda genus for an application in biomedicine in 
hepato-, neuro- and athero-protection. Several lines of 
results have documented the ability of a hydrophilic 
extract from this seaweed to target free-radical mediated 
processes in vitro cell culture and in vivo experimental 
models (Rivero et al., 2003; Fallarero et al.,  2003; 
Linares et al., 2004; Mancini-Filho et al., 2009; de 
Oliveira e Silva et al., 2012). In previous studies, in vitro 
Halimeda spp seaweeds have been described as having 
a relationship between antioxidant activity and 
antiatherogenic properties (Costa-Mugica et al., 2012). 
Additionally, it has been shown that Halimeda spp. has a 
high phenolic content (Vidal et al., 2009; Vidal et al., 
2011), together with low amounts of other antioxidants, 
such as ascorbate, β-carotene, chlorophylls, and 
selenium, and that these compounds may be able to 
explain antioxidant properties.  
Thus, in view of these previous considerations, the  aim  
of this study was to evaluate the antioxidant properties of 
the hydrophilic fractions obtained from the green 
seaweed Halimeda incrassata, in free radical scavenging, 
and in animal models, and a possible relation to 
lipoprotein oxidation, and macrophage oxidative stress,  
as pathological stages of atherosclerosis. 
 
 
MATERIALS AND METHODS 
 
Seaweed collection and hydrophilic extract preparation 
 
The seaw eed Halimeda incrassata (Ellis) Lamouroux (Chlorophyta, 
Bryopsidales) w as collected during December 2011 in the Bajo de 
Santa Ana, La Habana, Cuba. Voucher specimens w ere authenticated 
by Dr. A. M. Suárez from the Seaw eeds Laboratory at the Marine 
Research Center of the University of Havana. Freshly collected 
specimens w ere w ashed w ith distilled w ater and dried at room 
temperature for 3-5 days. After milling and sieving, the dry pow der w as 
used to obtain the hydrophilic extracts. The dry seaw eed pow der w as 
extracted w ith distilled w ater (1:5 w /v) at room temperature and 
centrifuged at 800 g and at 4ºC for 20 min. The supernatant w as 
recovered, lyophilized, and kept at -20ºC until use. The w eight yield of 
the f inal extract in terms of dry seaw eed w as 5%. The lyophilized 
material w as dissolved in distilled w ater at know n concentrations for the 
different studies. The lyophilized material w as denominated as being an 
aqueous extract.  
Polyphenolic rich fractions w ere obtained according to Krygier et al. 
(1982). Tetrahydrofurane extraction was performed on the dry seaw eed 
in order to obtain a fraction rich in free phenolic acids (FPA). The w eight 
yield of the f inal dry fraction in terms of dry seaw eed w as 0.8%. 
 
 
Total phenolic concentration 
 
The total phenolic content w as determined by the Folin-Ciocalteau 
assay as previously described by Vidal et al. (2009) and expressed as 
µg of Gallic Acid Equivalents (GAE) /g of sample. The calibration curve 
w as obtained in the range of 100-1000 µg gallic acid/ml. 
 
 
DPPH• radical scavenging assay 
 
The free radical scavenging activity of the Halimeda incrassata extract 
w as done similar to Goupy et al. (1999). Briefly, 0.6 ml of the extract (10 
to 40 μg GAE) w as mixed w ith 0.6 mL of a methanolic  solution of DPPH• 
(60 μM). Absorbance was measured in time. Radical scavenging activity 
w as calculated relative to the reference absorption as a Percentage 
Inhibition (PI) (%) = (1-Asample/Areference) × 100. IC50 w as the antioxidant 
quantity needed (mg aqueous extract or fraction dry) to scavenge 50% 
of DPPH•. 
 
 
Hydroxil scavenging and Fe 3+ chelating capacity  
 
Antioxidant protection in 2-desoxi-D-ribose oxidation by hydroxil radicals 
w as quantif ied by the malondialdehyde formation according to Aruoma 
(1994).  The reaction mix w as 850 µL phosphate  buffer  (KH2PO4/KOH)  
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10 mM, pH 7.4, w ith or w ithout 50 µL EDTA 100 µM and 50 µl FeCl3 25 
µM. After 1 min, 50 µl 2-desoxi-D-ribose 2.8 mM and H2O2 2.8 mM w ere 
added. Reaction w as initiated w ith 50 µL 100 µM ascorbic acid and 
stopped after 1 h at 37oC. The degree of oxidation w as assessed by a 
TBARS formation. Samples w ere incubated w ith 1 ml TBA 1%, 1mL 
TCA 2.8%, at 80°C for 20 min. Absorbance w as monitored at 532 nm. 
Without EDTA, the assay indicated the Fe chelating capacity of the 
extract, w hereas w ith EDTA, it measured the hydroxil radical 
scavenging activity.  
 
 
Antioxidant activity protecting against liver damage in CCl4 –
induced Wistar rats 
 
Animals and treatment schedule  
 
Male Wistar rats from the University of  São Paulo, Brazil, w eighing 120 
g–150 g, w ere maintained under a controlled diet, w ith cycles of 12 h of 
light/dark, at 25 °C and 60% humidity. The rats had free access to w ater 
and to a standard food diet according to the care guidelines for 
laboratory animals used in research. The animal studies w ere approved 
by the Institutional Ethical Committee for Animal Experimentation from 
the Faculty of Pharmaceutical Sciences (USP), Brazil. 
Hepatic injury w as induced in the rats by an intraperitoneal 
administration of a single dose of 3 mL CCl4 (mixed 1:1 w ith olive oil) on 
day 21. Gallic Acid (GA) w as used as a reference. 
The animals w ere grouped as follow s: 
 
Group I: Control, treated daily w ith vehicle (1 ml, p.o.) for 21 days. 
Group II: Treated daily w ith vehicle (1.0 mL, p.o.) for 21 days, follow ed 
by treatment w ith CCl4. 
Group III: Treated daily w ith an aqueous extract of Halimeda incrassata 
(300 mg/kg, p.o.) for 21 days, follow ed by treatment w ith CCl4. 
Group IV: Treated daily w ith ferulic acid (20 mg/kg, p.o.) for 21 days, 
follow ed by treatment w ith CCl4. 
 
At the end of the treatment (day 22), a blood sample and the liver of 
each animal w as collected. ASAT and ALAT w ere determined by 
commercial laboratory kits (LABTEST).  
 
 
TBARS assay 
 
As a marker of lipid peroxidation, the TBARS contents w ere measured 
in the liver homogenates and serum of the animals using the method of 
Ohkaw a et al. (1979). The results w ere expressed as nmol/mg protein. 
 
 
Glutathione (GSH) analysis  
 
The hepatic total of GSH content w as measured using the method of 
Ellman (1959) as the change in absorbance w as monitored at 410 nm 
for 5 min, and the GSH level w as calculated by using pure GSH as 
standard. 
 
 
Determination of superoxide dismutase (SOD) activity  
 
The cytoplasmatic SOD activity w as evaluated according to McCord 
and Fridovich (1969) by using 100 mM cytochrome C, 500 mM 
xanthine, 1 mM EDTA, and 200 mM KCN in 0.05 M potassium 
phosphate, pH 7.8. The xanthine oxidase (same volume in the blank) 
w as placed in a glass tube along w ith 15 μl of the cytosolic fraction from 
each liver tissue. The results w ere expressed as U/mg protein. One unit 
(U) w as the enzyme activity that induced 50% of inhibition of the 
xanthine reaction at 25 °C, pH 7.8. 
 
 
 
 
Determination of catalase (CAT) activity 
 
The activity w as evaluated by the decomposition of hydrogen peroxide 
caused by the cytoplasmatic enzyme CAT according to Beutler (1975), 
through the decrement of the optic density at 230 nm (coeff icient of the 
molar extinction 0.0071 mM–1 cm –1) at 37 °C. One U of CAT 
corresponded to the enzyme activity that hydrolyzed 1 molecular w eight 
of H2O2 per minute at 37 °C, pH 8.0. The activity w as expressed as 
U/mg of protein. 
 
 
Expression of hepatic enzymes in rats by RT/PCR 
 
RNA Extraction: CAT and SOD gene evaluation  
 
RNA w as extracted from the rat liver utilizing a 100 mg sample and 1 
mL of trizol reagent (Invitrogen). The extract w as kept at room 
temperature for 5 min w ith the addition of 200 μl chloroform (Merck). 
The samples w ere mixed by vortexing for 15 s and kept at room 
temperature for 5 min. After this, they w ere centrifuged at 12,000 × g for 
15 min at 4 °C. 400 μl of the supernatant w as removed, avoiding the 
interphase, and mixed w ith 500 μl of isopropanol by vortexing for 5 s. 
These samples w ere then centrifuged at 12,000 × g for 5 min at 4 °C, 
discarding the supernatant. To the resulting pellet, 1000 μl of ethanol 
(75%) w as added and gently mixed, follow ed by centrifugation at 7500 × 
g for 10 min at 4°C, discarding the supernatant. Finally, 20 μl of distilled 
w ater, RNAse-free, w as added and incubated at 50 °C for 10 min. This 
material w as then stored at -70°C. 
 
 
Reverse transcription 
 
2 μg of RNA w ere added to 1.0 μl of primers (SOD or CAT), 1.0 μl of 10 
mM dNTP, and 4.0 μL of sterile distilled w ater. The reaction w as started 
by heating at 65°C for 5 min; then it w as quickly chilled on ice. Next, 4.0 
μl of 5× f irst strand buffer (Invitrogen), 2.0 μl of 0.1 M DTT (Invitrogen), 
and 1.0 μl of RNAseOut Ribonuclease inhibitor (Invitrogen) w ere added 
and incubated at 37°C for 2 min. After that, 1.0 μl (200 U) of reverse 
transcriptase (M-MLV RT-Invitrogen) w as added and incubated at 37°C 
for 50 min. The reaction w as stopped by heating at 70 °C for 15 min. 
The PCR product (cDNA) w as stored at -70°C. 
 
 
PCR reaction for amplification 
 
5 μl of cDNA w as amplif ied in a volume of 50 μl containing 5 μl 20 mM 
Tris-HCl (hydroxymethyl aminomethane-hydrochloride) buffer, pH 8.4, 
500 mM KCl, 1.5 μl 50 mM MgCl2, 1 μl 10 mM dNTP, 35.1 μl diethyl 
pyrocarbonate (DEPEC), 1.0 μL of primers (SOD or CAT), and 0.4 μL (5 
U/μl) Taq polymerase. This reaction mixture w as w armed by a thermal 
cycler (Bio-Rad) at 94°C for 3 min and 35 cycles of 45 s at 94°C, 30 s at 
55°C, 1.3 min at 72°C, and 72°C for 10 min. Finally, the mixture w as 
cooled at 4°C for an indeterminate time. The PCR amplif ied product 
w as analyzed by a 2.0% agarose gel (Sigma) electrophoretic run (60 V). 
The bands, stained w ith 0.5 μg/mL ethidium bromide, w ere documented 
by a f luorescent table (Vilber-Lourmat) and photographed by a digital 
camera (Sony). The bands w ere revealed w ith –262 bp (C to T) from 
the primers used to CAT genotyping and +242 bp (C to T) from the 
primers used to SOD genotyping (Promega, Madison/USA): 
 
Primer SOD 1 – sequence (5’ to 3’): TCT AAG AAA CAT GGC GGT 
CC.  
Primer SOD 2 – sequence (5’ to 3’): CAG TTA GCA GGC CAGCAG AT. 
Primer CAT 1 – sequence (5’ to 3’): GCG AAT GGA GAG GCA GTG 
TAC. 
Primer CAT 2 – sequence (5’ to 3’): GAG TGA CGT TGT CTT CAT 
TAG CAC TG. 
  
 
 
 
Effect of hydrophilic fractions on the inhibition of LDL oxidation 
mediated by Cu2+ and HRP/H2O2 
 
Oxidation experiments w ere conducted w ith heparin precipitated LDL 
(hep-LDL), a model of LDL that has interacted w ith extracellular matrix, 
and is, therefore, more prone to oxidation (Upritchard and Sutherland, 
1999). Lipoproteins w ere isolated from normolipemic human serum by 
the method of Wieland and Seidel (Wieland and Seidel, 1983). 5 ml 
sodium citrate buffer (64 mmol/L, pH 5.12) containing heparin (50 000 
UI/L) w as added to 0.5 mL serum. After incubating for 10 min at room 
temperature the sample w as centrifuged at 3000 rpm for 15 min. The 
Hep-LDL precipitate w as w ashed 3 times w ith a Hepes buffer (5 mM 
Hepes, 20 mM NaCl, 4 mM CaCl2 and 2 mM MgCl2, pH 7.2), then by 
centrifuging at 3000 rpm for 15 min; the hep-LDL w as w as next 
dissolved in a 0.5 mL phosphate buffer, pH 7.4, w ith NaCl 4%. The 
Hep-LDL fraction w as next divided into aliquots and kept at 4ºC. The 
cholesterol content w as determined by an enzymatic assay (Boehringer 
Mannhein Diagnostics) and the protein content by the Low ry method.  
In brief, for the oxidation, LDL (0.2 μmol cholesterol) w as diluted in a 
phosphate buffer and incubated in the presence or absence, of 
hydrophilic fractions (aqueous extract and FPA fraction) for 6 h at 37oC, 
w ith 10 μM Cu2+ , or HRP (119 U)/H2O2 (12.9 µM). The maximum 
degree of oxidation w as determined by TBARS as described in 
Frostegard et al. (1990) and expressed as nmoles MDA equivalents/ mg 
protein, using TMP as standard.  
 
 
Antioxidant activity of hydrophilic extracts in macrophages 
 
Cell experiments w ere done w ith the macrophage RAW 264.7 cell line. 
Cells w ere cultured in DMEM containing fetal bovine serum (FBS), 2 
mM L-glutamine and streptomycin/penicillin in 5% CO2.  
 
 
TBARS formation by cells  
 
For the assessment of antioxidant activity, cells w ere pre-incubated for 
24 h w ith an aqueous extract of Halimeda Incrassata. Lipoperoxidation 
levels w ere evaluated in the supernatant by a TBARS assay as in 
Frostegard et al. (2003).  
 
 
ROS production 
 
ROS production by cells w as determined in conditions similar to 
Kopprasch et al. (2008). Luminol 4 µM w as added to cells in a 50 mM 
Hepes buffered DMEM. After adding seaw eed, aqueous extracts cells 
w ere stimulated w ith opsonized zymosan (OZ) 1 mg/mL. 
Chimioluminiscent response w as measured in time, and amplitude of 
the curve w as taken as maximum ROS production. Experiments w ere 
done w ith a Lumi-Aggregometer from Chrono-Log Corporation w ith 
AGGRO/LINK softw are version 5.2.3.  
 
 
Statistical analysis 
 
Values are given as mean + standard deviation (s.d.) of experiments 
that w ere done in triplicate, and performed at least tw o independent 
times. In studies of the antioxidant activity in the cell systems, statistical 
signif icance w as determined by ANOVA w ith a Tukey posttest. 
Signif icant differences w ere concluded for p < 0.05. Data w ere 
processed using Microcal Origin and GraphPad Prism softw are.  
 
 
RESULTS AND DISCUSSION 
 
Over  the  last few  years,  seaweeds  have  been  widely 
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investigated as a source of bioactive compounds, with 
different attributes, and in this context, the genus 
Halimeda has been studied for different pharmacological 
properties, including antioxidant activity (Moo-Puc et al., 
2008; Nor et al., 2010). 
 
 
Phenolic content 
 
The phenolic content, as assessed in the Aqueous 
Extract and by the Fraction Phenolic Acids (FPA), was 
0.13 ± 0.05 and 0.47 ± 0.09 mg Gallic Acid Equivalents 
(GAE)/ g dry seaweed, respectively. Both fractions had a 
high phenolic content.  
The phenolic content found is in the range of the one 
for seaweeds of Halimeda spp. worked by our research 
group (12-13) and higher than for other seaweeds 
informed in the literature like Fucus vesiculosus 
(Phaeophyceae) and Caulerpa racemosa (Chlorophyta) 
(Jimenez-Escrig et al., 2001).  
The phenolic contribution to antioxidant activity was 
evaluated in the hydrophilic fractions. When comparing 
different fractions from the seaweed Eisenia bicyclis 
(Phaeophyceae), Kim et al. (2011) found that the highest 
phenolic content was associated with the antioxidant 
activity and the hepatoprotective effect, against tert-butyl 
hyperoxide damage (t-BHP) in hydrophilic fractions from 
the seaweed.  
In our previous work, Vidal et al. (2009) identified 8 
phenolic acids in Halimeda opuntia and H. monile 
(Chlrophyta) respectively. They reported that salicylic, 
cinnamic, gallic, pirogalic and cafeic acids were the 
principal polyphenolic compounds in both seaweeds. In 
Halimeda incrassata, it was identified that there were 
major polyphenolicqq compounds of salicylic and ferulic 
acids, and they suggested that their levels were related to 
the antioxidant activity of the seaweed (Vidal et al., 
2011). 
 Likewise, the antiatherogenic activity of phenolic 
compounds has been studied when considering their 
antioxidant properties as being the main mechanism of 
action (Bocanegra et al., 2009; Jimenez-Escrig et al., 
2001)  
 
 
Antioxidant activity in vitro: DPPH
•
 radical 
scavenging and hydroxyl scavenging and Fe
3+ 
chelating capacity  
 
DPPH
•
 radical scavenging was determined for the 
Aqueous Extract and FPA. Both fractions exhibited a 
concentration dependent on free radical scavenging 
activity (Figure 1). The FPA fraction had an IC50 value of 
0.46 mg of dry residue (27.1 µg of polyphenol); while the 
Aqueous Extract had an IC50 value of 5.75 mg of 
lyophilized substance (14.8 µg of polyphenol).  
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Figure 1. Scavenging activity of the DPPH• radical by hydrophilic fractions of H. incrassate. (A): Scavenging of DPPH• radicals by aqueous 
extracts in time. (B): Scavenging of DPPH• radicals by  a free phenolic acid fraction (FPA) in time. The assay w as performed according to 
Goupy et al. (1999). Values are given as a mean   S.D. (n = 3). After incubating, increasing extract concentration (0.4-1 mg for aqueous 
extract or 10-40 µg total polyphenols for FPA fraction) w ith DPPH• solution, absorbance w as measured at λ = 517 nm in time. 
 
 
 
DPPH
•
 radical scavenging has been widely used to study 
the activity of antioxidant molecules and plant extracts. It 
is considered, that presently, more than 90% of 
antioxidant studies use this method in combination with 
other assays (Goupy et al., 1999). In this work, free 
radical scavenging by DPPH
•
 assay indicated a dose-
dependent effect, and in comparison with Halimeda 
incrassata, a six-fold lower activity for Caulerpa 
racemosa, a more than 30-fold decrement in Ulva 
lactuca, and a similar activity in Sargasum spp.( 
Yangthong et al., 2009).  
Antioxidant activity by DPPH suggests phenolic 
compounds are relevant to the effect. Different authors 
(Dutra-Rocha et al., 2007) have indicated an association 
between the phenolic content of seaweeds and DPPH
•
 
scavenging. Previous results from our group, regarding 
Halimeda genus, have indicated an association of 
antioxidant activity in DPPH scavenging with phenolic 
content (Vidal et al., 2009; 2011). Indeed, Katsube et al. 
(2004) found a tendency of higher antioxidant activity in 
the inhibition of LDL oxidation, and of DPPH
•
 scavenging 
in plants with an increasing phenolic content. Hydroxyl 
radicals are a main initiator of lipid peroxidation. 
Thereafter, hydroxyl radical scavenging is a relevant 
indicator of the antioxidant activity of a natural compound, 
and in this area, plant polyphenols are compounds of 
interest, as they can react with these radicals to avoid 
oxidative damage (Stocker and Keaney, 2004). 
Aqueous seaweed extract inhibited desoxiribose 
oxidation with a dose-dependent effect both in the 
presence of EDTA (Figure 2A) (IC50 = 1.91± 0.09 
mg/mL), or in absence of EDTA (Figure 2B) (IC50 = 2.95 ± 
0.01 mg/mL Fe chelating).  Additionally, aqueous extracts 
had a concentration-dependent antioxidant effect, both 
with and without, EDTA, which is stronger than the one 
referred to for various antioxidant extracts (Vidal et al., 
2006).  
Antioxidants in Halimeda incrassata seaweed might 
offer protection from damage, by avoiding an attack by 
OH
• 
radicals, generated by a Fenton reaction in the 
presence of EDTA. On the other hand, when Fe
3+
 is 
added to the reaction milieu (in the absence of EDTA), 
some ions might join desoxiribose sugar and take part in 
the Fenton reaction. Antioxidant activity in this assay 
would then show the Fe
3+ 
chelating capacity of the
 
extracts. Thus, our results also indicated that the extracts 
have the capacity to interfere with the site specific 
generation of OH
•
, catalyzed by Fe 
3+ 
ions, bound to 
desoxiribose. Indeed, other authors have remarked that 
the   presence   of   phenolic   compounds   in   seaweeds  
A B 
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Figure 2. Inhibition of the oxidative degradation of 2-Desoxi-D-ribose by the aqueous extract of Halimeda incrassata (A) w ith EDTA, (B) 
w ithout EDTA. The assay w as performed as described by Aruoma (1994). Oxidation of desoxiribose w as done in the presence, or absence 
of, increasing concentrations of Halimeda incrassata. Values are given as a mean  S.D. (n=3). 
 
 
 
confers them with a heavy metal chelating capacity, 
which is also related to OH
. 
radical scavenging (Vidal et 
al., 2006; Yuan and Walsh, 2006). 
 
 
Antioxidant activity protecting against liver damage 
in CCl 4-induced Wistar rats 
 
Antioxidant and hepatoprotective properties of the 
aqueous extract from H. incrassata were investigated in 
Wistar rats with a CCl4-induced liver injury. Through the 
ASAT and ALAT activities (Table 1), it verified partial liver 
injuries caused by CCl4. We observed that the rats 
treated with an aqueous extract from H. incrassate, or 
Ferulic acid, proved to be capable of attenuating the toxic 
effect produced by CCl4. As will be appreciated, it was 
observed that a partial recuperation occurred with an 
aqueous extract from H. incrassata. In previous work, 
Mancini et al. (2009) reported similar results when 
investigating polyphenol fractions from Halimeda monile. 
These results are also in accordance with de Oliveira et 
al. (2012) whom investigated the hepatoprotective 
properties of polyphenolic fractions from H. opuntia under 
an experimental model CCl4 injury. Tanigushi et al. 
(Tanigushi et al., 2004) reported that hepatic damage by 
CCl4 may occur  in  a  range  of  between  6  to  12 h after 
CCl4 administration, and that restoration starts after 48 h. 
It is possible then to suppose that FPA- H. incrassata-
treated rats had a faster recovery from liver injury at 24 h 
than expected, criterion that is concordant with our 
results.  
In Table 1, it may be appreciated that TBARS levels in 
the liver tissues of CCl4-treated rats increased, confirming 
the successful induction of oxidative damage, while pre-
treatment with H. incrassata (300 mg/kg) led to an 
approximate 50% reduction in liver TBARS levels. A 
previous study from our laboratory showed that an 
aqueous extract from H. incrassata was effective in 
significantly reducing serum and brain TBARS levels and 
other parameters in rats with oxidative stress induced by 
methyl-mercury (2004). According to de Oliveira e Silva 
et al. (2012), a pre-treatment with polyphenol rich 
fractions from Halimeda opuntia led to reductions in 
serum and liver TBARS. Kim et al. (2011) also observed 
a comparable reduction in hydroperoxide levels in the 
liver, relative to the CCl4-treated group, in a study of rats 
fed on Saengshik, a non-cooked food containing 
vegetables and seaweeds. 
Animals with liver injuries caused by CCl4 had GSH 
levels increased statistically in respect of all groups, while 
in an aqueous extract from the H. incrassata group was 
observed with only minor values. According to Chan et al.  
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Table 1. Values of parameters and enzymes in serum and liver tissue relative to oxidative stress. 
 
GROUPS 
Serum Liver 
AST 
U/mL 
ALT 
U/mL 
TBARS 
nmol/mg protein 
GSH 
µmol 
CAT 
U/mg protein 
SOD 
U/mg protein 
Control 84.36 ± 0.61
bc
 57.68 ± 2.70
b
 0.19 ± 0.02
b
 0.10 ± 0.02
c
 219.91 ± 23.11
a
 26.61 ± 2.71
b
 
CCl4 116.30 ± 11.68
a
 90.87 ± 20.08
a
 0.87 ± 0.21
a
 0.65 ± 0.11
a
 144.24 ± 32.46
b
 29.76 ± 3.85
ab
 
H. incrassata 300 99.86 ± 10.18
ac
 67.76 ± 11.69
ab
 0.43 ± 0.12
b
 0.42 ± 0.10
bd
 173.90 ± 23.86
ab
 32.25 ± 1.40
a
 
Ferulic acid 20 112.25 ± 10.22
a
 78.59 ± 13.11
ab
 0.56 ± 0.29
ab
 0.55 ± 0.12
ad
 154.18 ± 40.77
b
 33.22 ± 3.73
a
 
 
SD. Different letters indicate statistically signif icant differences, *p < 0.05. 
 
 
 
(Chan et al., 2001), these increased levels may be 
explained as an adaptive response of the rats reacting 
against the oxidative stress introduced by CCl4. 
The CAT and SOD enzymes are considered to be as a 
fundamental antioxidant defense system in mammals, 
and it was demonstrated that CCl4 treatment significantly 
reduced the activities of these enzymes. In this study, we 
observed the ability of CCl4 to diminish the antioxidant 
enzyme activities. 
As may be appreciated in Figure 3, treatment with the 
seaweed led to a significant increase in the activity of the 
CAT enzyme, which in turn resulted in an enhanced 
antioxidant defense. These results suggest antioxidant 
and hepatoprotective activities of the phenolic fraction of 
H. incrassata. Ozturk et al. (2003) observed in the CCl4-
treated group significant increases in kidney CAT activity. 
These results are in agreement with Mancini-Filho et al. 
(2009) that reported a considerable increase in the 
activity of CAT in rats treated with a polyphenol-rich 
fraction similar to that from Halimeda monile. High 
antioxidant enzyme activity has been reported through 
repeated administration of Sargassum spp. 
(Phaeophyceae) extracts (Raghavendran et al., 2005). 
Treatment with Caulerpa prolifera (Chlorophyta) and 
Laurencia obtusata (Rhodophyta) extracts also led to a 
rise in enzyme activity (Abdel-Wahhab et al., 2006). 
 
 
Expression of CAT hepatic enzymes by PCR- RT 
 
When considering results from antioxidant enzyme 
activities, only the expression of Catalase by PCR-RT 
technique was studied. As can be seen in Figure 4, the 
levels of CAT in liver tissues partially increased with a 
treatment of seaweed and a posterior CCl4 
administration, which shows alterations in the expression 
of catalase genes.  
Treatment with H. incrassata aqueous extract (band 3) 
resulted in a higher catalase gene expression when 
compared with that observed in the CCl4-treated group 
(band 2).  A  review  by   Stevenson   and   Hurst   (2007) 
 
 
 
discusses recent evidence that polyphenols also have an 
indirect antioxidant effect through the induction of 
endogenous protective enzymes, and that these inductive 
or signaling effects may occur at concentrations much 
lower than those required for effective radical 
scavenging. Vidal et al. (2011) reported that a total 
phenolic contents of the hydrophilic fractions from H. 
incrassata were 255 μg of gallic acid equivalents/g of 
fresh seaweed, which more than half (63%) corresponds 
to free phenolic acids, and in this fraction, about 32% was 
identified as salicylic acid, while a small fraction was 
associated to ferulic acid. Yeh and Yen (2006) suggested 
that these three phenolic acids, including ferulic acid, 
modulate the phase II antioxidant enzymes and the 
phase II sulphate conjugative enzymes; and they seem to 
selectively induce hepatic mRNA transcripts for CAT, 
probably through the up-regulation of gene transcription, 
as well as the Nrf2 transcription factor. In previous results 
from our group, Mancini-Filho et al. (2009) reported an 
over-expression of CAT genes by treatment with FPA 
from Halimeda monile; while de Oliveira e Silva et al. 
(2012) showed that by using (RT/PCR) analysis 
increased the catalase (CAT) gene expression in the 
group treated with free phenolic acid (FPA) fractions from 
Halimeda opuntia, suggesting inducing effects on the 
enzyme. 
 
 
Effect of Halimeda incrassata hydrophilic fractions 
on the inhibition of LDL oxidation mediated by Cu
2+
 
and HRP/H2O2 
 
The atheroprotective potential of Halimeda incrassata 
was determined through its effect on LDL oxidation. The 
inhibition of LDL oxidation by Cu
2+
, or HRP/H2O2, was 
dose dependent, with a higher concentration needed for 
the aqueous extract than for the FPA fraction (Table 2). It 
was compared with the two oxidation systems relevant to 
LDL oxidation in the artery wall:  by Cu
2+
, or HRP/H2O2; 
and by studying the antioxidant effect in the mediated 
transition metal and independent LDL  oxidation  (Stocker 
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Figure 3. Activity of (A) SOD and (B) CAT liver tissues from 
control, CCl4-treated, Ferulic acid-treated, and Halimeda 
incrassata-treated rats. Different letters indicate statistically 
signif icant differences, *p < 0.05. 
 
 
 
and Keaney, 2004). As shown, seaweed hydrophilic 
fractions had an inhibitory effect on both models of LDL 
oxidation, indicating its potential in atheroprotection.  
The inhibition of LDL oxidation is considered a key 
target in atherosclerosis management, since oxidized 
LDL levels are presently one of the main emerging 
factors for cardiovascular risk (Kang et al., 2003; Levitan 
et al., 2010). In vivo is a complex process, and there is no 
certainty as to the precise mechanism of the initiation of 
lipoperoxidation in the vascular wall (2004). In the quest 
for the atheroprotective potential of natural compounds, 
different researchers have   determined   the   antioxidant   
properties of seaweed extracts in the inhibition of LDL 
oxidation (Bocanegra et al., 2009; Jimenez-Escrig et al., 
2001; Yang et al., 2011).  
The activity of the inhibition of LDL-oxidation found in 
this work is promissory when compared to other natural 
extracts. Hseu et al. (2008) found 37% inhibition of 
TBARS formation in oxidation mediated by AAPH and 
74% in peroxidation mediated by Cu
2+ 
ions. In this study, 
the Toona sinensis extracts had 6.5 μg GAE, a phenolic 
content in the range of the one needed in our study for 
the 50% inhibition of TBARS formation by Halimeda 
incrassata extracts.  
creasing concentrations of Halimeda incrassata. Values are given as a mean  S.D. (n=3). 
 
 
 
Figure 3. Activity of (A) SOD and (B) CAT  liver tissues from control, CCl4-treated, 
Ferulic acid-treated, and Halimeda incrassata-treated rats. Different letters indicate 
statistically significant differences, *p < 0.05. 
 
a 
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a a 
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Figure 4. Electrophoresis of the expression of catalase 
hepatic enzyme in rats by RT/PCR. Experimental groups: 
Bands: (1) Control; (2) CCl4; (3) H. incrassata 300 mg/Kg; 
(4) Ferulic acid 20 mg/Kg. 
 
 
 
Table 2. Inhibitory effect of H. incrassata hydrophilic fractions on LDL oxidation 
induced by Cu2+ ions or peroxidase (HRP/H2O2), w ith or w ithout increasing seaw eed 
extract concentration. TBARS formation w as determined according to Frostegard et 
al. (1990). 
 
Fractions 50% inhibitory concentration (IC50) of H. incrassata 
 Cu
2+
 HRP 
Aqueous extract  (mg) 10.42 ± 0.295 1.09 ± 0.005 
FPA  (mg) 0.33 ± 0.04 0.66 ± 0.02 
 
 
 
LDL oxidation studies were done with LDL that had 
interacted with heparin as a model of glycosaminoglycan 
since it has been reported that lipoproteins that have 
interacted with glycosaminoglycans are more susceptible 
to oxidation (Upritchard and Sutherland, 1999). In the 
case of peroxidase, this is associated with a change in 
the lipoprotein structure, giving an increased access of 
peroxidase to apo B, and forming free radicals from apo 
B and vitamin E that would mediate the oxidation of lipids 
by mieloperoxidase and HRP. The mechanism is different 
from Cu
2+
 mediated oxidation, where free radical 
formation and peroxidation takes place directly in the lipid 
phase.    
Other authors have evaluated the effect of natural 
extracts in the inhibition of LDL oxidation by peroxidases. 
Wang et al. (2003) found a significant decrement in 
TBARS formation in extracts from C. mukul on LDL 
oxidation mediated by lypoxigenases. The extracts also 
had an antiatherogenic action in the inhibition of 
cholesterol uptake by macrophages and LDL oxidation 
mediated by Cu
2+
 ions.  
Few studies approach the effect of antioxidants in LDL 
oxidation mediated by HRP. It has been shown that in 
this area, vitamin E acts by transferring radicals, from the 
aqueous to the lipid phase, and does  not  protect  it  from 
oxidation. However, in the presence of vitamin C, 
oxidation mediated by peroxidases is inhibited, as in this 
case, vitamin C acts as a co-antioxidant avoiding the 
formation of α-tocoferoxil (Upritchard and Sutherland, 
1999). Other antioxidants, like some phenolic hydrophilic 
compounds, act synergistically in the scavenging of free 
radicals protecting vitamin E, licopene and β-carotene, 
contained in LDL from oxidation (Kaliora et al., 2006). 
The antilipoperoxidative activity of the hydrophilic 
fractions of Halimeda incrassate, in this model, indicates 
that the extracts are efficient in the inhibition of oxidation 
mediated by protein radicals, and add evidence to the 
antiatherogenic and antioxidant potential.  
Other authors have obtained an excellent activity of 
antilipoperoxidation for Halimeda incrassata in β-carotene 
linoleate systems, with an inhibition of bleaching of 75% 
for Halimeda incrassate, while for Bryothamnion 
triquetrum seaweed , the activity was 20% at a dose of 2 
mg (Rivero et al., 2003; Vidal et al., 2011).  
Our results are also comparable to the work of Yuan 
and Walsh (2006) with a significant inhibition of 
conjugated dienes and TBARS formation, during the 
oxidation of linoleic acid for an aqueous extract from the 
Palmaria palmate seaweed, suggesting that the 
antioxidant activity was  due  to  the  complex  mixture  of  
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Figure 5. Correlation of antioxidant activity by different methodologies. A. Association of antioxidant activity in OH. radical 
scavenging and the inhibition of LDL oxidation mediated by Cu2+ ions (r2= 0.997). B. Association of antioxidant activity in Fe ion 
chelation and the inhibition of oxidation of LDL mediated by Cu2+ (r2= 0.943).  
 
 
 
antioxidants present in the extract, with the presence of 
chlorophyll, polyphenols, carotene, and ascorbate.  
 
 
Association of antioxidant activity in Fe Ions 
chelation and the inhibition of oxidation of LDL 
mediated by Cu
2+ 
 
 
The association of antioxidant activity and the inhibition of 
LDL-oxidation, evaluated by different methodologies in 
this paper, were performed to explain the antioxidant 
mechanisms of Halimeda incrassata. Figure 5A and B 
indicate the positive correlation between the inhibition of 
desoxiribose oxidation, with or without EDTA, and the 
inhibition of LDL oxidation mediated by Cu
2+ 
(r
2
= 0.997 
and 0.943 respectively).  
In this work, a positive correlation was found between 
the scavenging of OH
• 
radicals in the inhibition of the 
desoxiribose assay in the presence of EDTA (r
2
 = 0.997), 
and the inhibition of LDL oxidation mediated by Cu
2+
. A 
similar behavior was obtained for the chelating effect of 
metal ions in the inhibition of desoxiribose oxidation 
assay in the absence of EDTA (r
2
 = 0.943) and the 
inhibition of LDL oxidation mediated by Cu
2+
.  
The results of the correlation of antioxidant activity in 
Fe ion chelation and the  inhibition of oxidation of LDL 
mediated by Cu
2+
 suggest that the mechanism of action 
in the inhibition of LDL oxidation by hydrophilic fractions 
could be associated with the antioxidant properties of the 
seaweed in metal ion chelating and free radical 
scavenging.  
Antioxidant activity of hydrophilic extracts of 
Halimeda incrassata in macrophages 
 
As shown in Figure 6A, the degree of cell lipoperoxidation 
was decreased by about two-fold in the presence of 
Halimeda incrassata seaweed extract. The FPA fraction 
also inhibited TBARS production, indicating the 
contribution of phenolic compounds to the effect.  
The improvement of antioxidant activity was also 
shown by the 1.2 fold decrement in ROS levels by the 
treatment with Halimeda incrassata aqueous extract, 
when aqueous extracts were added immediately before 
stimulation (Figure 6A), or by a nearly 50% decrement in 
ROS levels, when aqueous extracts were added 24 h 
before stimulation of the cells (Figure 6B).   
The macrophages associated with oxidative stress are 
directly involved in the atherosclerosis progression, so 
when evaluating compounds of interest for 
atheroprotection antioxidant activity, it is frequently 
sought at the macrophage level (Kaliora et al., 2006).  
A decreased peroxide basal content was found in the 
cell supernatant as a result of the preincubation with 
seaweed hydrophilic extracts. About a 3.3 fold higher 
concentration was required from the FPA fraction for it to 
reach a similar   inhibition   of MDA formation as to that 
of1.5 µg GAE/mL (0.5 mg/mL) for the aqueous extract. 
To evoke ROS production in macrophages, opsonized 
zymosan was added to the cells after the addition of 
aqueous seaweed extracts. About a 20% decrement in 
ROS production was found with the highest 
concentrations of seaweed used in  the  assay.  Seaweed  
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Figure 6. Antioxidant activity of hydrophilic extracts of Halimeda incrassata in macrophages. (A). TBARS levels in cell 
supernatant w ere determined as in Frostegard et al., 1990. (B) and (C) ROS production by cells after stimulation w ith 
zymosan w as determined by luminol chemiluminiscence as in Kopprasch et al., 2003. Experiments w ere performed by 
adding aqueous extract immediately before cell stimulation (B) or by preincubating cells w ith extracts for 24 hours 
before stimulation (C).  Signif icant differences w ere determined by ANOVA w ith a Tukey post test, ** p < 0.001. 
 
 
 
preincubation with the cells improved the antioxidant 
capacity with a 50% decrement in ROS production with 
the highest concentration tested (1 mg/mL).  
These results are in agreement with previous studies 
by our group for the aqueous extracts of Halimeda 
incrassata (Chlorophyta) and Bryothamnion triquetrum 
(Rhodophyta) seaweeds, and where basal and H2O2 
elicited peroxides were decreased in the GT1-7 
hypothalamic cells in the presence of the seaweeds 
(Fallarero et al.,  2003).  
Indeed, the antioxidant activity of natural extracts in 
macrophages has also been assessed by other authors 
that have found a decreased macrophage peroxidation 
and ROS production by incubation with phenolic rich 
extracts. Yang et al. (2011) found a 1.5% decrement in 
the peroxide levels in oxLDL stimulated macrophages, 
after preincubation with 1mg/mL mulberry leaf extracts 
(where quercetin, gallocatechin gallate and naringenin 
were the main polyphenolic constituents identified). The 
atheroprotective effect was related to an elevation of 
antioxidant enzymes GPx and SOD by the extracts.  
Likewise, a  significant inhibition  of  peroxidation was 
found in cells stimulated with oxLDL after preincubation 
with anthocyanin rich purple sweet potato extracts (0.5-
0.6 mg/mL); that also inhibited the LDL uptake by 
macrophages and had antioxidant activity in DPPH
•
 
scavenging (Park et al., 2010).  
The antioxidant activity in macrophages has been 
studied by other groups that have found improved  in vitro 
and in vivo antioxidant capacity, as a result of different 
phenolic rich extract supplementation (Aviram et al., 
2008). Targeting oxidative stress as a cause of 
atherosclerosis progression, they have correlated 
phenolic content, in vitro antioxidant activity in DPPH
•
 
radical scavenging, and the atheroprotective effect in 
macrophages (evaluated as the inhibition of LDL uptake, 
decreased macrophage peroxidation, and increased 
antioxidant enzyme activity) to be in vivo atheroprotection 
in apo E-/- mice.  
 
 
Conclusion 
 
In this work, the antioxidant activity in in vitro cell free 
systems and cell systems for the hydrophilic fractions 
from Halimeda incrassata was evaluated. Previously, it 
identified phenolic acids in hydrophilic fractions as being 
the main active components (salicylic and ferulic acid). It 
also tested the phenolic contribution to the antioxidant 
activity for a FPA fraction. A significant antioxidant activity 
was found in both cell free and cell systems. However, a 
higher concentration of FPA fraction was required to have 
a similar effect as for the one with the aqueous extracts. 
It is then possible to suppose that phenolic acids in the 
extract to be of relevance for the activity, since both 
ferulic and salicylic acids have been found to have 
antioxidant and antinflammatory properties that decrease 
the macrophage activation. Additionally, different  authors  
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have shown a synergic effect in the antioxidant and 
antiatherogenic properties from seaweed crude extract, 
and this improved antioxidant activity could also be 
related to the synergism between the polyphenolic 
compounds and/or with other antioxidants. Halimeda spp. 
contains antioxidants like ascorbate, β-carotene, 
chlorophylls, among other compounds that might 
contribute to the effect.   
In summary, this study adds further evidence about the 
beneficial properties of Halimeda incrassata as an 
antioxidant and as an antiatherogenic for a future 
phytotherapeutic application. 
 
 
Conflict of Interests 
 
The authors have not declared any conflict of interests. 
 
 
ACKNOWLEDGEMENTS 
 
The authors  want to express their gratitude to Conselho 
Nacional de Desenvolvimento Científico e Tecnológico 
(CNPq) (Brazil) for the financial support provided by 
Project ¨Aspectos nutrigenómicos de las algas marinas 
como fuentes de antioxidantes¨ and the IFS by Project 
IFS Research Agreement ·F/4897-1 “Seaweeds as a 
source of natural antioxidants: atheroprotective properties 
of hydrophilic extracts from Halimeda incrassata”.  
 
 
REFERENCES 
 
 Abdel-Wahhab A, Ahmed HH, Hagazi MM (2006). Prevention of 
aflatoxin B1-initiated hepatotoxicity in rat by marine algae extracts. J. 
Appl. Toxicol. 26(3):229-238. 
Antioxidant activities of Toona Sinensis leaves extracts using different 
antioxidant models. Food Chem. Toxicol. 46:105-114.  
Aruoma OI (1994). Deoxyribose assay for detecting hydroxyl radicals .In: 
Methods in Enzymology. New  York Academic Press 233:57-66. 
Aviram M, Volkova N, Coleman  R, Dreher M, Reddy MK, Ferreira D, 
Rosenblat M (2008). Pomegranate Phenolics from the Peels, Arils, 
and Flow ers Are Antiatherogenic: Studies in vivo in Atherosclerotic 
Apolipoprotein E-Deficient (E0) Mice and in vitro in cultured 
macrophages and lipoproteins. J Agric. Food Chem. 56(3):1148-
1157. 
Beutler E (1975). Red cell metabolism: manual of biochemical methods. 
New  York: Grune & Stratton. pp. 89-90. 
Bocanegra A, Bastida S, Benedí J, Ródenas S,  Sánchez-Muniz FJ 
(2009).Characteristics and Nutritional and Cardiovascular-Health 
Properties of Seaw eeds. J. Med. Food 12(2):236-258.  
Chan K, Han X-D, Kan YW (2001). An important function of Nrf2 in 
combating oxidative stress: Detoxif ication of acetaminophen. Proc. 
Natl. Acad. Sci. USA 98(8):4611-4616. 
Costa-Mugica A, Batista- Gonzalez AE, Mondejar D, Soto-López Y, 
Brito-Navarro V,  Vázquez AM, Brömme D, Zaldívar-Muñoz C, Vidal-
Novoa A, de Oliveira e Silva AM, Mancini-Filho J ( 2012). Inhibition of 
LDL-oxidation and antioxidant properties related to the polyphenols 
content of hydrophilic fractions from seaw eed Halimeda incrassata 
(Ellis) Lamouroux. Braz. J. Pharm. Sci. 48(1):31-37.  
De Oliveira  e  Silva  AM,  Vidal-Novoa  A,  Batista-González  AE,  Pinto  
Vidal-Novoa et al.           219 
 
 
 
JR, Portari Mancini DA, Reina-Urquijo W, Mancini-Filho J  (2012). In 
vivo and in vitro antioxidant activity and hepatoprotective properties 
of polyphenols from Halimeda opuntia (Linnaeus) Lamouroux.  Redox 
Rep. 17(2):47-53.    
Dutra-Rocha F, Crespo-Pereira R, Coelho-Kaplan MA, Laneuville-
Teixeira V (2007).Produtos naturais de algas marinhas e seu 
potencial antioxidante. Br.  J.  Pharmacogn. 17(4):631-639.   
Ellman GL (1959). Tissue sulfhydryl groups. Arch. Biochem. Biophys. 
82:70-77. 
Fallarero A, Loikkanen JJ, Mannisto PT, Castañeda O, Vidal A (2003). 
Effects of aqueous extracts of Halimeda incrassata (Ellis) Lamouroux 
and Bryothamnion triquetrum (S.G.Gmelim) How e on hydrogen 
peroxide and methyl mercury-induced oxidative stress in GT1-7 
mouse hypothalamic immortalized cells. Phytomedicine 10:39-47. 
Frostegard J, Nilsson J, Haegerstrand A, Hamsten A, Wigzell H, 
Gidlund M (1990). Oxidized low  density lipoprotein induces 
differentation and adhesion of human monocytes and the monocytic 
cell line U937. Proc. Natl. Acad. Sci. USA. 87:904-908. 
Goupy P, Hugues M, Boivin P, Amiot MJ (1999).Antioxidant 
composition and activity of barley (Hordeum vulgare) and malt 
extracts and of isolated phenolic compounds. J. Sci. Food 
Agric.79:1625-1634.  
Hseu YC, Chang WH, Chen CS, Liao JW, Huang CJ, Lu FJ, Chia YC, 
Hsu HK, Wu JJ, Yang HL (2008). Antioxidant activities of Toona 
sinensis leaves extracts using different antioxidant models. Food 
Chem Toxicol. 46:105-114. 
Jimenez-Escrig A, Jimenez-Jimenez I, Pulido R, Saura-Calixto F 
(2001).Antioxidant activity of fresh and processed edible seaw eeds. 
J. Sci. Food Agric. 81:530-534.  
Kaliora AC, Dedoussis GVZ, Schmidt H (2006). Dietary antioxidants in 
preventing atherogenesis. Atherosclerosis187:1-17.  
Kang K, Park Y, Hw ang HJ, Kim SH, Lee JG, Shin HC 
(2003).Antioxidative properties of brow n algae polyphenolics and 
their perspectives as chemopreventive agents against vascular risk 
factors. Arch. Pharm. Res. 26(4):286-293. 
Katsube T, Tabata H, Ohta Y,Yamasaki Y, Anuurad E, Shiw aku K, 
Yamane Y (2004).Screening for Antioxidant Activity in Edible Plant 
Products: Comparison of Low -Density Lipoprotein Oxidation Assay, 
DPPH Radical Scavenging Assay, and Folin-Ciocalteu Assay. J. 
Agric. Food Chem. 52:2391-2396.  
Kim SM,  Kang K,  Jeon JS,  Jho EH,  Kim CY,  Nho CW,  Um BH 
(2011). Isolation of phlorotannins from Eisenia bicyclis and their 
hepatoprotective effect against oxidative stress induced by tert-butyl 
hyperoxide.  Appl. Biochem. Biotechnol. 165(5-6):1296-1307.  
Kopprasch S, Pietzsch J, Graessler J (2003).Validation of different 
chemilumigenic substrates for detecting extracellular generation of 
reactive oxygen species by phagocytes and endothelial cells. 
Luminiscence 18:268-273. 
Krygier K, Sosulski F, Hogge L (1982). Free, esterif ied, and insoluble-
bound phenolic acids. 1. Extraction and purif ication procedure. J. 
Agric. Food Chem. 30:330-334.  
Levitan I, Volkov S, Subbaiah PV (2010). Oxidized LDL: Diversity, 
patterns of recognition and pathophysology. Antioxid. Redox Signal. 
13(1):1-37. 
Linares AF, Loikkanen J, Jorge MF, Soria RB, Novoa AV (2004) 
.Antioxidant and neuroprotective activity of the extract from the 
seaw eed, Halimeda incrassata (Ellis) Lamouroux, against in vitro and 
in vivo toxicity induced by methyl-mercury. Vet.  Hum. Toxicol. 
46(1):1-5.  
Mancini-Filho J, Vidal A, Batista AE, De Andrade-Wartha ERS, De O e 
Silva AM, Pinto JR, Portari-Mancini DA (2009). Free phenolic acids 
from the seaw eed Halimeda monile w ith an antioxidant effect 
protecting against liver injury. Z Naturforsch C. 64c:657-663.  
McCord JM, Fridovich I (1969). Superoxide dismutase. An enzyme 
function for erythrocuprein (hemocuprein). J. Biol. Chem. 244:6049-
6055. 
Moo-Puc R, Robledo D, Freile-Pelegrin Y (2008).Evaluation of selected 
tropical    seaw eeds    for    in    vitro   anti-trichomonal    activity.     J.  
 220          Afr. J. Agric. Res. 
 
 
 
Ethnopharmacol. 120:92-97. 
Nor AS, Darah I, Shaida FS, Jain NM-K, Mohd NAZ 
(2010).Antimicrobial activity of various extracts of a tropical 
Chlorophyta macroalgae Halimeda discoidea. J. Appl. Sci. 
10(23):3007-3013. 
Ohkaw a H, Ohishi H, Yagi K (1979). Assay for lipid peroxides in animal 
tissues by thiobarbituric acid reaction. Anal. Biochem. 95:351-358. 
Oxidized low  density lipoprotein induces differentation and adhesion of 
human monocytes and the monocytic cell line U937. Proc. Natl. 
Acad. Sci. USA. 87:904-908.  
Ozturk F, Ucar M, Ozturk IC, Vardi N, Batcioglu K (2003).Carbon 
tetrachloride-induced nephrotoxicity and protective effect of betaine in 
Sprague-Daw ley rats. Urology 62:353-356. 
Park K-H, Kim JR, Lee J-S, Lee H, Cho KH (2010).  Ethanol and Water 
Extract of Purple Sw eet Potato Exhibits Anti-Atherosclerotic Activity 
and Inhibits Protein Glycation. J. Med. Food. 13(1):91-98. 
Raghavendran HR, Sathivel A, Devaki T (2005) .Effect of Sargassum 
polycystum (Phaeophyceae)-sulphated polysaccharide extract 
against acetaminophen-induced hyperlipidemia during toxic hepatitis 
in experimental rats. Mol. Cell Biochem. 276:89-96.  
Rivero F, Fallarero A, Castañeda O, Dajas F, Manta E, Areces A, 
Mancini Filho J, Vidal A (2003).Antioxidant activity in vivo and in vitro 
of Halimeda incrassata aqueous extracts. Food Sci. Technol. 
(Campinas) 23:256-263.  
Sanchez-Recalde A, Kaski JC (2001). Diabetes mellitus, inflamación y 
aterosclerosis coronaria: perspectiva actual y futura. Rev. Esp. 
Cardiol. 54:751-763.  
Stevenson DE, Hurst RD (2007).Polyphenolic phytochemicals – just 
antioxidants or much more? Cell Mol. Life Sci. 64:2900-2916. 
Stocker R, Keaney (jr) JF (2004).Role of Oxidative Modif ications in 
Atherosclerosis. Physiol. Rev. 84:1381-1478.  
Tanigushi M, Takeuchi T, Naktusuka R, Watanabe T, Sato K 
(2004).Molecular process in acute liver injury and regeneration 
induced by carbon tetrachloride. Life Sci.75:1539-1549. 
Upritchard JE, Sutherland WHF (1999). Oxidation of heparin-treated low  
density lipoprotein by peroxidases. Atherosclerosis 146:211-219. 
Vidal A, Fallarero A,De Andrade-Wartha SER, De Oliveira e Silva AM,  
De Lima A, Pavan R, Vuorela P, Mancini-Filho J (2006). Composición 
química y actividad antioxidante del alga marina roja Bryothamnion 
triquetrum (S.G.Gmelin) How e. Br. J. Pharm. Sci. 43(4):589-600. 
Vidal A, Silva De Andrade-Wartha ER, De Oliveira  AM, Pavan R, Lima 
A, Fallarero A, Batista AE,Mancini-Filho J (2009). Actividad    
antioxidante y polifenoles de algas marinas verdes Halimeda opuntia 
y Halimeda monile. Ars Pharmaceutica 50(1):24-31.   
  
 
 
 
 
 
 
 
Vidal A, Silva de Andrade-Wartha ER, Fallarero A, De Oliveira AM, 
Vuorela P, Mancini-Filho J (2011).Antioxidant activity and bioactive 
components from the seaw eed Halimeda incrassata (Ellis) 
Lamouroux. Br. J. Pharmacogn. 21(1):53-57.  
Wang X, Greilberger J, Ledinski G, Kager G, Paigen B, Jurgens B 
(2003).The hypolipidemic natural product Commiphora mukul and its 
component guggulsterone inhibit oxidative modif ication of LDL. 
Atherosclerosis 172(2):239-246. 
Wieland H, Seidel S (1983). A simple specif ic method for precipitation of 
low  density lipoproteins. J. Lipid Res. 241(7): 904-909.  
Yang MY, Huang CN, Chan KC, Yang YS, Peng CH, Wang CJ (2011). 
Mulberry leaf polyphenols possess antiatherogenesis effect via 
inhibiting LDL oxidation and foam cell formation. J. Agric. Food 
Chem. 59:1985-1995. 
Yangthong M, Hutadilok-Tow atana N, Phromkunthong W (2009). 
Antioxidant Activities of Four Edible Seaw eeds from the Southern 
Coast of Thailand. Plant Foods Hum. Nutr. 64:218-223. 
Yeh C-T, Yen G-C (2006).Induction of hepatic antioxidant enzymes by 
phenolic acids in rats is accompanied by increased levels of 
multidrug resistance–associated protein 3 mRNA expression. J. Nutr. 
136:11-15.  
Yuan YV, Walsh NA (2006).Antioxidant and antiproliferative activities of 
extracts from a variety of edible seaw eeds. Food Chem. Toxicol. 
44:1144-1150.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
. 
  
 
 
 
 
